20 November 2017
News and Views
Links and Services
January's issue of Gut assesses healthcare costs and productivity losses in a large cohort of IBD patients.
The introduction of anti tumor necrosis factor-α (anti-TNFα) therapy might impact healt
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors